-
1
المؤلفون: Kim Linton, Sridhar Chaganti, Kate Cwynarski, Josh Wright, Dominic Culligan, Roderick J. Johnson, Stefanie Thust, Ayesha S. Ali, Louise Hopkins, Aimee Jackson, Jeffery Smith, Andrew Davies, Andrés J.M. Ferreri, Shireen Kassam, Christopher P. Fox, Catherine Thomas, Ian Chau, David J. Lewis, Graham P. Collins, Nicolas Martinez-Calle, Dorothee P. Auer, Graham McIlroy
المصدر: Fox, C P, Ali, A S, McIlroy, G, Thust, S, Martinez-Calle, N, Jackson, A E, Hopkins, L M, Thomas, C M, Kassam, S, Wright, J, Chaganti, S, Smith, J, Chau, I, Culligan, D, Linton, K M, Collins, G P, Ferreri, A J M, Lewis, D, Davies, A J, Johnson, R, Auer, D P & Cwynarski, K 2021, ' A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma : the TIER trial ', Blood Advances, vol. 5, no. 20, pp. 4073-4082 . https://doi.org/10.1182/bloodadvances.2021004779
مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, ThioTEPA, Neutropenia, Transplantation, Autologous, Lymphoma, Non-Hodgkin/drug therapy, Autologous stem-cell transplantation, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Chemotherapy, Ifosfamide, Manchester Cancer Research Centre, business.industry, Lymphoma, Non-Hodgkin, Antineoplastic Combined Chemotherapy Protocols/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, Hematopoietic Stem Cell Transplantation, Primary central nervous system lymphoma, Hematology, Thiotepa/therapeutic use, medicine.disease, Combined Modality Therapy, Regimen, Rituximab, business, Thiotepa, medicine.drug
وصف الملف: text
-
2
المؤلفون: Marion M. Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, Brian Middleton, Marcel Nijland, Lydia Visser, Sebastian Patzke, Helen Heyerdahl, Arne Kolstad, Trond Stokke, Anne Hansen Ree, Jostein Dahle
المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL)
المصدر: PLoS ONE, 17(4):e0267543. PUBLIC LIBRARY SCIENCE
مصطلحات موضوعية: Tumor, Multidisciplinary, Lymphoma, Lymphoma, Non-Hodgkin, Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors/pharmacology, Poly(ADP-ribose) Polymerase Inhibitors, Radioimmunotherapy, Piperazines, Cell Line, Lymphoma, Non-Hodgkin/drug therapy, Cell Line, Tumor, Non-Hodgkin/drug therapy, Humans, Phthalazines, Antineoplastic Agents/pharmacology
وصف الملف: application/pdf
-
3
المؤلفون: Patrick Schmid, Enos Bernasconi, Ioannis Theodorou, Sophia S. Wang, Pejman Mohammadi, Paul J. McLaren, Huldrych F. Günthard, Matthias Cavassini, Charles S. Rabkin, Matthias Hoffmann, Christian Hammer, Shehnaz K. Hussain, Jacques Fellay, Andri Rauch, Cécile Goujard, Laurence Meyer, Jonathan Niay, Caroline Besson, Nava Ehsan, Tiphaine Oudot-Mellakh, Dominique Costagliola, Manuel Battegay, Christian W. Thorball, Federico Santoni
المساهمون: Ecole Polytechnique Fédérale de Lausanne (EPFL), Swiss Institute of Bioinformatics [Lausanne] (SIB), Université de Lausanne (UNIL), Service de Biochimie Métabolique et Centre de Génétique moléculaire et chromosomique [CHU Pitié Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), The Scripps Research Institute [La Jolla], University of California [San Diego] (UC San Diego), University of California-University of California, Genentech, Inc. [San Francisco], Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Service de Médecine Interne - Immunologie Clinique [AP-HP Bicêtre], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Beckman Research Institute of the City of Hope, Cedars-Sinai Medical Center, Lausanne University Hospital, Bern University Hospital [Berne] (Inselspital), University of Bern, University Hospital Basel [Basel], Cantonal Hospital of Olten, Cantonal Hospital St Gallen (KSSG), Lugano Regional Hospital [Lugano], University hospital of Zurich [Zurich], National Microbiology Laboratory [Winnipeg, Canada], Public Health Agency of Canada, University of Manitoba [Winnipeg], Centre Hospitalier de Versailles André Mignot (CHV), University of Zurich, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
المصدر: Haematologica
Haematologica, Ferrata Storti Foundation, 2021, 106 (8), pp.2233-2241. ⟨10.3324/haematol.2020.247023⟩
Haematologica, vol. 106, no. 8, pp. 2233-2241مصطلحات موضوعية: 10028 Institute of Medical Virology, Follicular lymphoma, HIV Infections, Genome-wide association study, 10234 Clinic for Infectious Diseases, 0302 clinical medicine, MESH: Lymphoma, Non-Hodgkin, hemic and lymphatic diseases, BATF, Immunodeficiency, Lymphoma, AIDS-Related, variants, 0303 health sciences, education.field_of_study, common, Anti-Retroviral Agents/therapeutic use, Case-Control Studies, Chemokine CXCL12, Genome-Wide Association Study, HIV Infections/complications, HIV Infections/drug therapy, HIV Infections/genetics, Humans, Lymphoma, AIDS-Related/drug therapy, Lymphoma, Non-Hodgkin/drug therapy, Lymphoma, Non-Hodgkin/genetics, Polymorphism, Genetic, Lymphoma, Non-Hodgkin, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, MESH: HIV Infections, Hematology, MESH: Case-Control Studies, 3. Good health, Anti-Retroviral Agents, 030220 oncology & carcinogenesis, loci, MESH: Chemokine CXCL12, Population, 610 Medicine & health, Biology, MESH: Anti-Retroviral Agents, Article, infected individuals, 03 medical and health sciences, follicular lymphoma, expression, MESH: Polymorphism, Genetic, Genetic variation, cancer-risk, medicine, education, MESH: Lymphoma, AIDS-Related, 030304 developmental biology, Genetic association, MESH: Humans, chemokine, medicine.disease, Lymphoma, MESH: Genome-Wide Association Study, Immunology, genome-wide association, immunodeficiency
وصف الملف: 1062233.pdf - application/pdf; application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e896ca36e59f52f7ebdd6a72f38073b
https://doi.org/10.3324/haematol.2020.247023 -
4
المؤلفون: Rogier Mous, Ada Azaryan, Brian Elliott, Tommy Li, Dena DeMarco, Martine E.D. Chamuleau, Kim Linton, David John Lewis, Anna Sureda Balari, Roberto S. Oliveri, Pieternella J. Lugtenburg, Martin Hutchings, Michael Roost Clausen, Kuo mei Chen, Tahamtan Ahmadi, David Cunningham, Peter Johnson, Christopher Chiu
المساهمون: Hematology, CCA - Cancer Treatment and quality of life
المصدر: The Lancet, 398(10306), 1157-1169. Elsevier Limited
The Lancet, 398(10306), 1157-1169. Elsevier Ltd.
Hutchings, M, Mous, R, Clausen, M R, Johnson, P, Linton, K M, Chamuleau, M E D, Lewis, D J, Sureda Balari, A, Cunningham, D, Oliveri, R S, Elliott, B, DeMarco, D, Azaryan, A, Chiu, C, Li, T, Chen, K M, Ahmadi, T & Lugtenburg, P J 2021, ' Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma : an open-label, phase 1/2 study ', The Lancet, vol. 398, no. 10306, pp. 1157-1169 . https://doi.org/10.1016/S0140-6736(21)00889-8
Hutchings, M, Mous, R, Clausen, M R, Johnson, P, Linton, K M, Chamuleau, M E D, Lewis, D J, Sureda Balari, A, Cunningham, D, Oliveri, R S, Elliott, B, DeMarco, D, Azaryan, A, Chiu, C, Li, T, Chen, K, Ahmadi, T & Lugtenburg, P J 2021, ' Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma : an open-label, phase 1/2 study ', The Lancet, vol. 398, no. 10306, pp. 1157-1169 . https://doi.org/10.1016/S0140-6736(21)00889-8
Hutchings, M, Mous, R, Clausen, M R, Johnson, P, Linton, K M, Chamuleau, M E D, Lewis, D J, Sureda Balari, A, Cunningham, D, Oliveri, R S, Elliott, B, DeMarco, D, Azaryan, A, Chiu, C, Li, T, Chen, K M, Ahmadi, T & Lugtenburg, P J 2021, ' Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study ', The Lancet, vol. 398, no. 10306, pp. 1157-1169 . https://doi.org/10.1016/S0140-6736(21)00889-8مصطلحات موضوعية: Male, medicine.medical_specialty, Injections, Subcutaneous, Gastroenterology, Lymphoma, Non-Hodgkin/drug therapy, Pharmacokinetics, Refractory, Refractory B-Cell Non-Hodgkin Lymphoma, Internal medicine, Medicine, Humans, Adverse effect, Aged, CD20, biology, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Lymphoma, Non-Hodgkin, General Medicine, medicine.disease, United Kingdom, Lymphoma, Europe, Cytokine release syndrome, biology.protein, Female, Refractory Follicular Lymphoma, business
وصف الملف: text; application/pdf
-
5
المؤلفون: Ellen Ingalla, Deepak Sampath, Franck Morschhauser, Kylie D. Mason, Guillaume Cartron, Martine E.D. Chamuleau, Arijit Sinha, Divya Samineni, Edith Szafer-Glusman, Constantine S. Tam, Carla Casulo, Andre Goy, Pieternella J. Lugtenburg, Christian Klein, Steven Le Gouill, Adam M. Petrich, Mehrdad Mobasher, Andrew D. Zelenetz, Gilles Salles, Hervé Tilly, Sylvia Herter, Martin Kornacker, Laurie H. Sehn
المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Memorial Sloane Kettering Cancer Center [New York], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), The Royal Melbourne Hospital, University of Rochester Medical Center (URMC), Centre hospitalier universitaire de Nantes (CHU Nantes), BC Cancer Agency (BCCRC), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Service d'hématologie et oncologie médicale, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), VU University Medical Center [Amsterdam], Hackensack University Medical Center [Hackensack], University of Melbourne, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Abbvie Inc. [North Chicago], Roche Products Ltd, Genentech, Inc. [San Francisco], Roche Innovation Center Zurich, Genentech, Inc., F. Hoffmann-La Roche [Basel], Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
المصدر: Blood, 133(18), 1964-1976. American Society of Hematology
Blood
Blood, 2019, 133 (18), pp.1964-1976. ⟨10.1182/blood-2018-11-880526⟩
Blood, American Society of Hematology, 2019, 133 (18), pp.1964-1976. ⟨10.1182/blood-2018-11-880526⟩
Zelenetz, A D, Salles, G, Mason, K D, Casulo, C, le Gouill, S, Sehn, L H, Tilly, H, Cartron, G, Chamuleau, M E D, Goy, A, Tam, C S, Lugtenburg, P J, Petrich, A M, Sinha, A, Samineni, D, Herter, S, Ingalla, E, Szafer-Glusman, E, Klein, C, Sampath, D, Kornacker, M, Mobasher, M & Morschhauser, F 2019, ' Venetoclax plus R-or G-CHOP in non-Hodgkin lymphoma: Results from the CAVALLI phase 1b trial ', Blood, vol. 133, no. 18, pp. 1964-1976 . https://doi.org/10.1182/blood-2018-11-880526مصطلحات موضوعية: Male, Oncology, Follicular lymphoma, CHOP, MESH: Antineoplastic combined chemotherapy protocols/therapeutic use, Bridged bicyclo compounds, Heterocyclic/therapeutic use, Lymphoma, Non-Hodgkin/drug therapy, Sulfonamides/therapeutic use, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Obinutuzumab, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, B-cell lymphoma, Sulfonamides, 0303 health sciences, Lymphoma, Non-Hodgkin, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, Middle Aged, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, 3. Good health, Vincristine, 030220 oncology & carcinogenesis, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Rituximab, medicine.drug, medicine.medical_specialty, Maximum Tolerated Dose, Immunology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Cyclophosphamide, Aged, 030304 developmental biology, business.industry, Venetoclax, Cell Biology, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, chemistry, Doxorubicin, Prednisone, business, Diffuse large B-cell lymphoma
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45edbe7d7ecd20cef61fcc3b7604581d
https://hdl.handle.net/1765/117144 -
6دورية أكاديمية
المؤلفون: Beguin, Yves, Weber, Georges
المصدر: Journal of Clinical Oncology, 22(16), 3429; author reply 3430. United States (2004).
مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Disease Progression, Drug Resistance, Neoplasm, Hodgkin Disease/drug therapy/pathology, Humans, Lymphoma, Non-Hodgkin/drug therapy/pathology, Selenium/blood, Tumor Markers, Biological/blood, Human health sciences :: Hematology, Sciences de la santé humaine :: Hématologie
URL الوصول: https://orbi.uliege.be/handle/2268/6965
-
7
المؤلفون: Catarina Xavier, Kevin Van der Jeught, Matthias D'Huyvetter, Tony Lahoutte, Ahmet Krasniqi, Jan Tavernier, Serge Muyldermans, José Van der Heyden, Nick Devoogdt
المساهمون: Supporting clinical sciences, Faculty of Medicine and Pharmacy, Medical Imaging, Clinical sciences, Laboratory of Molecullar and Cellular Therapy, Basic (bio-) Medical Sciences, Cellular and Molecular Immunology, Department of Bio-engineering Sciences, Translational Imaging Research Alliance
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, mice, medicine.drug_class, medicine.medical_treatment, Follicular lymphoma, Monoclonal antibody, Theranostic Nanomedicine, Targeted therapy, 03 medical and health sciences, Lymphoma, Non-Hodgkin/drug therapy, 0302 clinical medicine, Antigen, Antigens, CD20/metabolism, medicine, Theranostic Nanomedicine/methods, Animals, Humans, Radioimmunotherapy/methods, B-cell lymphoma, business.industry, Lymphoma, Non-Hodgkin, Radioimmunotherapy, medicine.disease, Antigens, CD20, Lymphoma, Disease Models, Animal, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Immunology, Cancer research, Rituximab, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0e2db8577a4ffa2f938493a70720ed
https://hdl.handle.net/20.500.14017/7e1bb7f8-ff7a-461b-8940-b26013579f08 -
8
المؤلفون: Patricia Bijttebier, Sabine Deprez, Jurgen Lemiere, Anne Uyttebroeck, Marina Danckaerts, Rudi D'Hooge, Stefaan Van Gool, Veerle Labarque, Iris Elens
المساهمون: Neurology
مصطلحات موضوعية: Oncology, Male, Cancer Research, Pathology, Methotrexate/adverse effects, medicine.medical_treatment, Cognition Disorders/cerebrospinal fluid, Neuropsychological Tests, 0302 clinical medicine, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Young adult, Medicine(all), phosphorylation, Lymphoma, Non-Hodgkin, Wechsler Adult Intelligence Scale, survivors, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, Antimetabolites, Antineoplastic/adverse effects, Survival Rate, Leukemia, 030220 oncology & carcinogenesis, young adult, Female, medicine.drug, Adult, medicine.medical_specialty, Antimetabolites, Antineoplastic, Childhood leukemia, Adolescent, tau Proteins, Case-control studies, 03 medical and health sciences, Lymphoma, Non-Hodgkin/drug therapy, Internal medicine, medicine, Humans, Biomarkers/cerebrospinal fluid, Survival rate, Retrospective Studies, Chemotherapy, business.industry, tau Proteins/cerebrospinal fluid, medicine.disease, Methotrexate, Cross-Sectional Studies, business, Cognition Disorders, Neurocognitive, 030217 neurology & neurosurgery, Biomarkers
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a6b9e32b02b522dc67b2415d144df9e
https://biblio.vub.ac.be/vubir/neurocognitive-sequelae-in-adult-childhood-leukemia-survivors-related-to-levels-of-phosphorylated-tau(c90140f8-e555-40bf-8e74-936006d36baf).html -
9
المؤلفون: Santana, Adriell Ramalho, Amorim, Fábio Ferreira, Soares, Paulo Henrique Alves, de Moura, Edmilson Bastos, Maia, Marcelo de Oliveira
المصدر: Revista Brasileira de Terapia Intensiva
مصطلحات موضوعية: Lung diseases, interstitial, Drug toxicity, Case reports, Tomography, X-ray computed, Lymphoma, non-Hodgkin/drug therapy, Case Report, Respiratory insufficiency, Cryptogenic organizing pneumonia, respiratory tract diseases
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::767e6543950ac512a18ee7718e0bd691
http://europepmc.org/articles/PMC4031816 -
10
المؤلفون: Pavlidis, Nicholas, Aamdal, S., Awada, Ahmad, Calvert, H., Fumoleau, P., Sorio, R., Punt, C., Verweij, J., Oosterom, A. T. Van, Morant, R., Wanders, J., Hanauske, A. R.
المساهمون: Medical Oncology, Pavlidis, Nicholas [0000-0002-2195-9961]
المصدر: Cancer Chemotherapy and Pharmacology, 167-171
STARTPAGE=167;ENDPAGE=171;ISSN=0344-5704;TITLE=Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy & Pharmacology, 46, 167-171. Springer-Verlag
Cancer Chemotherapy and Pharmacology, 46, pp. 167-171
Cancer chemotherapy and pharmacologyمصطلحات موضوعية: Oncology, Male, Cancer Research, Indoles, Lymphoma, medicine.medical_treatment, Phases of clinical research, Toxicology, Ovarian neoplasms, Breast cancer, hemic and lymphatic diseases, Neoplasms, Antineoplastic agents, Solid tumors, Melanoma/drug therapy, Pharmacology (medical), Prodrugs, Head and neck cancer, Infusions, Intravenous, Bone marrow depression, Melanoma, Priority journal, Ovarian Neoplasms, Carzelesin, Leukopenia, Lymphoma, Non-Hodgkin, Ovarian Neoplasms/drug therapy, Colorectal Neoplasms/drug therapy, Blood toxicity, Middle Aged, Clinical trial, Head and Neck Neoplasms, Nonhodgkin lymphoma, Female, medicine.symptom, Intravenous, Colorectal Neoplasms, Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use, Human, Adult, Infusions, medicine.medical_specialty, Neutropenia, Fever, Ovary cancer, Stomach cancer, Stomach neoplasms, Antineoplastic Agents, Breast Neoplasms, Major clinical study, Bone marrow toxicity, Prodrugs/adverse effects/*therapeutic use, Head and neck neoplasms, Article, Colorectal neoplasms, Benzofurans/administration & dosage/adverse effects/*therapeutic use, Covalent bond, Lymphoma, Non-Hodgkin/drug therapy, Experimental diagnostics and therapy of malignancies, Duocarmycins, Breast Neoplasms/drug therapy, SDG 3 - Good Health and Well-being, Stomach Neoplasms, Advanced cancer, Internal medicine, medicine, Humans, Phase 2 clinical trial, Aged, Benzofurans, Neoplasm Staging, Indoles/administration & dosage/adverse effects/*therapeutic use, Pharmacology, Non-hodgkin, Chemotherapy, Toxicity, business.industry, Cancer, Head and Neck Neoplasms/drug therapy, Neoplasms/*drug therapy/pathology, medicine.disease, Thrombocytopenia, Colorectal cancer, Surgery, Non-Hodgkin's lymphoma, Stomach Neoplasms/drug therapy, Breast neoplasms, business
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.